Trial · NCT00825565
Results by group286
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 20 of 286
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Blister/Erosion Reduction Based on Change in Body Surface Area (BSA) Coverage | Allantoin 3% Cream | Baseline assessment | 57.25 | Standard Deviation 19.1 | percentage of BSA involvement |
| Blister/Erosion Reduction Based on Change in Body Surface Area (BSA) Coverage | Allantoin 3% Cream | Week 4 assessment | 39.40 | Standard Deviation 24.1 | percentage of BSA involvement |
| Blister/Erosion Reduction Based on Change in Body Surface Area (BSA) Coverage | Allantoin 3% Cream | Week 8 assessment | 27.25 | Standard Deviation 17.9 | percentage of BSA involvement |
| Blister/Erosion Reduction Based on Change in Body Surface Area (BSA) Coverage | Allantoin 3% Cream | Week 12 assessment | 25.45 | Standard Deviation 21.1 | percentage of BSA involvement |
| Target Wound Size Reduction or Closure | Allantoin 3% Cream | Baseline assessment | 8 | number of unhealed target wounds | |
| Target Wound Size Reduction or Closure | Allantoin 3% Cream | Week 12 assessment | 1 | number of unhealed target wounds | |
| Physician Global Assessment of Severity (PGAS) | Alwextin Cream | Baseline / PGAS score of 1 | 0 | Participants | |
| Physician Global Assessment of Severity (PGAS) | Alwextin Cream | Baseline / PGAS score of 2 | 0 | Participants | |
| Physician Global Assessment of Severity (PGAS) | Alwextin Cream | Baseline / PGAS score of 3 | 0 | Participants | |
| Physician Global Assessment of Severity (PGAS) | Alwextin Cream | Baseline / PGAS score of 4 | 0 | Participants | |
| Physician Global Assessment of Severity (PGAS) | Alwextin Cream | Baseline / PGAS score of 5 | 0 | Participants | |
| Physician Global Assessment of Severity (PGAS) | Alwextin Cream | Baseline / PGAS score of 6 | 0 | Participants | |
| Physician Global Assessment of Severity (PGAS) | Alwextin Cream | Baseline / PGAS score of 7 | 1 | Participants | |
| Physician Global Assessment of Severity (PGAS) | Alwextin Cream | Baseline / PGAS score of 8 | 2 | Participants | |
| Physician Global Assessment of Severity (PGAS) | Alwextin Cream | Baseline / PGAS score of 9 | 3 | Participants | |
| Physician Global Assessment of Severity (PGAS) | Alwextin Cream | Baseline / PGAS score of 10 | 2 | Participants | |
| Physician Global Assessment of Severity (PGAS) | Alwextin Cream | Month 1 / PGAS score of 1 | 0 | Participants | |
| Physician Global Assessment of Severity (PGAS) | Alwextin Cream | Month 1 / PGAS score of 2 | 0 | Participants | |
| Physician Global Assessment of Severity (PGAS) | Alwextin Cream | Month 1 / PGAS score of 3 | 0 | Participants | |
| Physician Global Assessment of Severity (PGAS) | Alwextin Cream | Month 1 / PGAS score of 4 | 0 | Participants |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT00825565/results